N-[2-(2-chlorophenyl)-6-[2-(dimethylamino)ethyl]pyrimidin-4-yl]-5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine
C20H19ClFN7 — CID 44519860
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(2-chlorophenyl)-6-[2-(dimethylamino)ethyl]pyrimidin-4-yl]-5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine
N-[2-(2-chlorophenyl)-6-[2-(dimethylamino)ethyl]pyrimidin-4-yl]-5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine (PubChem CID 44519860) has the molecular formula C20H19ClFN7 and a molecular weight of 411.87 g/mol. Its IUPAC name is N-[2-(2-chlorophenyl)-6-[2-(dimethylamino)ethyl]pyrimidin-4-yl]-5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine.
Molecular Properties
| Compound Name | N-[2-(2-chlorophenyl)-6-[2-(dimethylamino)ethyl]pyrimidin-4-yl]-5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine |
|---|---|
| PubChem CID | 44519860 |
| Molecular Formula | C20H19ClFN7 |
| Molecular Weight | 411.87 g/mol |
| Exact Mass | 411.14 |
| IUPAC Name | N-[2-(2-chlorophenyl)-6-[2-(dimethylamino)ethyl]pyrimidin-4-yl]-5-fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine |
| SMILES | CN(C)CCc1cc(Nc2[nH]nc3ncc(F)cc23)nc(-c2ccccc2Cl)n1 |
| InChI | InChI=1S/C20H19ClFN7/c1-29(2)8-7-13-10-17(25-19(24-13)14-5-3-4-6-16(14)21)26-20-15-9-12(22)11-23-18(15)27-28-20/h3-6,9-11H,7-8H2,1-2H3,(H2,23,24,25,26,27,28) |
| InChIKey | OTTBOKJLLMAYDY-UHFFFAOYSA-N |
| XLogP | 4.06 |
| TPSA | 82.62 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.87 |
| LogP ≤ 5 | 4.06 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 44519860 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.